SPP1 and early-onset autosomal dominant Alzheimer disease: Osteopontin levels were measured in plasma (Figure 5A) and CSF samples (Figure 5B) from patients with Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis and from healthy controls using the automated fluorescence-based Simple PlexTM Human OPN assay.